↓ Skip to main content

Trabectedin plus pegylated liposomal doxorubicin (PLD) versus PLD in recurrent ovarian cancer: Overall survival analysis

Overview of attention for article published in European Journal of Cancer (1965), April 2012

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (63rd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user
guideline
1 clinical guideline source

Readers on

mendeley
73 Mendeley